Bacteremia in Narcotic Addicts at the Detroit Medical Center. I. Microbiology, Epidemiology, Risk Factors, and Empiric Therapy
The DOI matches its Crossref record.
Abstract
The changing microbiology of bacteremia among narcotic addicts in Detroit raised concerns about current presumptive antimicrobial therapy. In a one-year study of incidence, microbiology, sites, and risk factors, 180 bacteremic addicts (15% of addict-related admissions) were followed prospectively. Cases of bacteremia were caused by methicillin-sensitive Staphylococcus aureus (33%), methicillin-resistant S. aureus (MRSA, 24%), streptococci (20%), mixed organisms (11%), Pseudomonas aeruginosa (9%), and miscellaneous other single organisms (3%). Endocarditis (41%) and abscess or cellulitis (34%) were usually found. Multivariate analysis of host factors and addiction habits yielded results predictive of bacterial species but not of infection sites. Previous hospitalization, long-term addiction, and nonprescribed antibiotic use were associated with MRSA acquisition (odds ratio, 8.6:1). All addicts with polymicrobial or P. aeruginosa bacteremia abused pentazocine and tripelennamine (P = .05). Many of the addicts with streptococcal bacteremia were women who did not abuse antibiotics (odds ratio, 20.7:1). Physicians inappropriately prescribed empiric antibiotics for 67 of 72 addicts with MRSA, P. aeruginosa, or polymicrobial infection. The results of regression analysis suggest that, guided by the patient's history, the physician can prescribe appropriate empiric antimicrobial therapy for bacteremia in the febrile addict in Detroit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Horstkotte, D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.008 · Cited by 730
Gould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Tacconelli, E., De Angelis, G., Cataldo, M. A., Pozzi, E., & Cauda, R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm416 · Cited by 435
Bacterial Infections in Drug Users
Gordon, R. J., & Lowy, F. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042823 · Cited by 329
Gram-positive Organisms and Sepsis
Bone, R. C. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.1.26 · Cited by 315
Mechanisms of Bacterial Resistance to Antibiotics
Dever, L. A. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.5.886 · Cited by 266
Injection drug use and right sided endocarditis
Moss, R., & Munt, B. (2003) · Heart · doi:10.1136/heart.89.5.577 · Cited by 265
Right-Side Endocarditis in Injection Drug Users: Review of Proposed Mechanisms of Pathogenesis
Frontera, J. A., & Gradon, J. D. (2000) · Clinical Infectious Diseases · doi:10.1086/313664 · Cited by 262
Levine, D. P., Crane, L. R., & Zervos, M. J. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.3.374 · Cited by 223
“causing bacteremia, regardless of the site of infection Detailed epidemiologic information on these patients is included in a separate report [10].”
BackgroundSelf-citationCutaneous complications of intravenous drug abuse
Del Giudice, P. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05607.x · Cited by 187
Serious Infections Other than Human Immunodeficiency Virus among Intravenous Drug Abusers
Haverkos, H. W., & Robert Lange, W. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.5.894 · Cited by 179
“Other outbreaks of endocarditis among IV drug abusers include Serratia marcescens infection in San Francisco [36], enterococcal infections in Cleveland [37], Pseudomonas cepacia infections in New York City [38], and methicillin-resistant Staphylcoccus aureus (MRSA) infections in Detroit [39].”
BackgroundSkin and soft tissue infections in injection drug users.
Ebright, J. R., & Pieper, B. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00017-x · Cited by 164
Spijkerman, I. J. B., van Ameijden, E. J. C., Mientjes, G. H. C., Coutinho, R. A., & van den Hoek, A. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00180-1 · Cited by 137
Staphylococcus aureus Infections in Injection Drug Users: Risk Factors and Prevention Strategies
Bassetti, S., & Battegay, M. (2004) · Infection · doi:10.1007/s15010-004-3106-0 · Cited by 118
“It caused, for example, 61% of endocarditis and 57% of bacteremias among IDUs admitted to one hospital in Detroit, Michigan, United States [15, 16], ten of 17 endocarditis episodes (59%) in a cohort of 521 IDUs followed for 5 years in Amsterdam,The Netherlands [17], five of seven cases of sepsis (71%) identified in th…”
Reyes, M. P., & Reyes, K. C. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0044-5 · Cited by 33
Jafari, S., Joe, R., Elliot, D., Nagji, A., Hayden, S., & Marsh, D. C. (2015) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-014-9511-4 · Cited by 33
Metadata
- Authors
- Crane, L. R., Levine, D. P., Zervos, M. J., & Cummings, G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1986-05-01
- Volume
- 8
- Issue
- 3
- Pages
- 364-373
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2314843836
- Cited by
- 126
- References
- 0
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.